Niva Bupa Health Insurance Receives IRDAI Show Cause Notice Following Regulatory Inspection

1 min read     Updated on 27 Feb 2026, 04:49 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Niva Bupa Health Insurance Company Limited received a Show Cause Notice and Letter of advice from IRDAI on February 26, 2026, following a February 2025 inspection. The regulatory action addresses violations of master circulars related to health insurance business, policyholder protection, and corporate governance. The company is responding to IRDAI and implementing compliance measures, stating no current impact on financial or operational activities.

33736779

*this image is generated using AI for illustrative purposes only.

Niva bupa health insurance company Limited has received a Show Cause Notice (SCN) and Letter of advice from the Insurance Regulatory and Development Authority of India (IRDAI) following a regulatory inspection. The company disclosed this development to stock exchanges on February 27, 2026, as required under SEBI listing regulations.

Regulatory Inspection and Subsequent Actions

IRDAI conducted an inspection of the company during February 2025, following which it issued observations that were duly replied to by the company. On February 26, 2026, at 1751 Hrs (IST), IRDAI issued both the Show Cause Notice and Letter of advice via email. The SCN relates to business and operational aspects of the company, while the Letter of advice provides compliance measures that the company must implement.

Nature of Violations Identified

The regulatory action stems from violations of certain provisions across multiple IRDAI master circulars:

Violation Category: Details
Master Circular: Health Insurance Business
Master Circular: Protection of Policyholders Interest
Master Circular: Corporate Governance
Authority: Insurance Regulatory and Development Authority of India
Communication Type: Letter of advice

Company's Response and Impact Assessment

The company is currently in the process of submitting its response to IRDAI regarding the Show Cause Notice. Additionally, Niva Bupa Health Insurance is implementing necessary actions as advised in the Letter of advice to ensure compliance with regulatory requirements.

Impact Assessment: Status
Financial Impact: None
Operational Impact: None
Other Activities Impact: None
Expected Financial Implications: None
Penalty or Sanctions: None

Regulatory Compliance Disclosure

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure includes detailed annexures providing comprehensive information about the regulatory communication, including the nature of violations and the company's response measures. Company Secretary and Compliance Officer Aparna Sharma signed the disclosure, confirming that the information provided is true, correct, and complete to the best of the company's knowledge and belief.

The company emphasized that there is no impact on financial, operational, or other activities arising from this regulatory action at this stage, and it remains committed to implementing the necessary compliance measures as advised by IRDAI.

Historical Stock Returns for Niva Bupa Health Insurance Company

1 Day5 Days1 Month6 Months1 Year5 Years
-1.82%-1.29%-2.48%-9.93%+1.86%+1.45%
Niva Bupa Health Insurance Company
View Company Insights
View All News
like18
dislike

Niva Bupa Health Insurance Announces Postal Ballot for Director Appointment and CEO Remuneration Revision

2 min read     Updated on 23 Feb 2026, 06:01 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Niva Bupa Health Insurance Company Limited has issued a postal ballot notice for two key resolutions: appointing Roger William John Davis as Non-Executive Director and revising MD & CEO Krishnan Ramachandran's remuneration for FY 2025-26. The e-voting period runs from February 25 to March 26, 2026, with results expected by March 28, 2026. Davis brings 40+ years of financial services experience, while Ramachandran's revised total fixed pay amounts to ₹4,12,75,648 per annum, approved by IRDAI.

33395496

*this image is generated using AI for illustrative purposes only.

Niva Bupa Health Insurance Company Limited has announced a postal ballot notice under Regulation 30 of SEBI Listing Regulations, seeking member approval for two significant corporate actions through remote e-voting.

Key Resolutions for Approval

The company is seeking shareholder consent for the following matters through ordinary resolutions:

Sr. No. Business Items
1. Appointment of Mr. Roger William John Davis (DIN: 11417248) as Non-Executive Director
2. Revision in Remuneration of Mr. Krishnan Ramachandran (DIN: 08719264), Managing Director & CEO, for FY 2025-26

E-Voting Schedule and Process

The company has engaged KFin Technologies Limited as the e-voting service provider. Members whose email addresses are registered as on the cut-off date of February 20, 2026, will be eligible to participate in the voting process.

Parameter Details
E-voting Commencement 09:00 A.M. (IST) on Wednesday, February 25, 2026
E-voting End 05:00 P.M. (IST) on Thursday, March 26, 2026
Results Declaration On or before Saturday, March 28, 2026
Scrutinizer Mr. Ranjeet Pandey (FCS No. 5922, COP No. 6087)

Director Appointment Details

Mr. Roger William John Davis, aged 69 years, brings extensive experience to the board. He holds an MA degree in Politics, Philosophy & Economics from the University of Oxford and served 12 years as an Officer in the British Army. With over 40 years of experience in financial services, he has previously served as Chairman of BUPA, Chairman of Sainsbury's Bank, and Non-Executive Director of Experian plc.

His appointment as Additional Director was effective January 29, 2026, based on recommendations from the Nomination & Remuneration Committee. The current postal ballot seeks formal shareholder approval for his continuation as Non-Executive Director.

CEO Remuneration Revision

The proposed revision in Mr. Krishnan Ramachandran's remuneration for financial year 2025-26 has received IRDAI approval dated November 11, 2025. The revised compensation structure includes:

Component Amount (₹ per annum)
Basic Salary 1,23,82,694
House Rent Allowance 61,91,347
Management Allowance 2,06,21,315
Provident Fund 14,85,923
Gratuity 5,94,369
Total Fixed Pay 4,12,75,648
Performance Bonus (Cash-projected) 2,94,08,900
Performance Bonus (ESOPs-projected) 6,86,20,766

Mr. Ramachandran, who holds 1,11,50,000 equity shares in the company, has been serving as Managing Director & CEO since May 01, 2020. He brings over 25 years of experience across health insurance, healthcare, and life sciences industries.

Compliance and Documentation

The postal ballot notice complies with MCA circulars and will be distributed electronically to eligible members. The notice is also available on the company's website at www.nivabupa.com , stock exchange websites, and KFin Technologies' e-voting portal. Members can access detailed explanatory statements and voting instructions through these platforms.

Historical Stock Returns for Niva Bupa Health Insurance Company

1 Day5 Days1 Month6 Months1 Year5 Years
-1.82%-1.29%-2.48%-9.93%+1.86%+1.45%
Niva Bupa Health Insurance Company
View Company Insights
View All News
like19
dislike

More News on Niva Bupa Health Insurance Company

1 Year Returns:+1.86%